2 active not recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
Follow Open Label: new trials by email Literature Review of Open Label trials Research Report on Open Label
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants TNX-102 SL Tablet - Pharmakokinetic, Open Label | Phase 1 | Active not recruiting | Tonix Pharmaceuticals, Inc. | 50 | 2025-12-09 | 2026-02-17 |
| A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma FX-909, Pembrolizumab (KEYTRUDA ®), KEYTRUDA ®( Pembrolizumab) - Advanced Urothelial Carcinoma, Oral Drug Administration | Phase 1 | Active not recruiting | Flare Therapeutics Inc. | 120 | 2023-08-24 | 2026-08-12 |
pembrolizumab (1)
Flare Therapeutics Inc. (1) · Tonix Pharmaceuticals, Inc. (1)
Canada (1) · United States (1)
Dan Rudin, MD (1) · Gopa Iyer, MD (1)